Vitamin K intake and mortality in people with chronic kidney disease from NHANES III

Clinical Nutrition

Volumn 34, Issue 2, 2015, Pages 235-240

  Cheung, Ching Lung ^a   Sahni, Shivani ^c,d   Cheung, Bernard M Y ^a   Sing, Chor Wing ^a   Wong, Ian C K ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Hebrew Senior Life   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cardiovascular disease; Chronic kidney disease; Mortality; Vitamin K; Warfarin

Indexed keywords

VITAMIN K GROUP; ANTIFIBRINOLYTIC AGENT; VITAMIN;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROPORTIONAL HAZARDS MODEL; SENSITIVITY ANALYSIS; VITAMIN INTAKE; AGED; BLOOD; CARDIOVASCULAR DISEASES; CHRONIC KIDNEY FAILURE; COMPLICATION; DOSE RESPONSE; INFORMATION PROCESSING; MIDDLE AGED; OBSERVATION; PROCEDURES;

ADULT; AGED; ANTIFIBRINOLYTIC AGENTS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DATA COLLECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBSERVATION; RENAL INSUFFICIENCY, CHRONIC; VITAMIN K; VITAMINS;

EID: 84924623843     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.03.011     Document Type: Article

References (30)

1. Pilkey R.M., Morton A.R., Boffa M.B., Noordhof C., Day A.G., Su Y., et al. Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis 2007, 49:432-439.
2. Holden R.M., Morton A.R., Garland J.S., Pavlov A., Day A.G., Booth S.L. Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol 2010, 5:590-597.
3. Danziger J. Vitamin K-dependent proteins, warfarin, and vascular calcification. Clin J Am Soc Nephrol 2008, 3:1504-1510.
4. McCabe K.M., Booth S.L., Fu X., Shobeiri N., Pang J.J., Adams M.A., et al. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int 2013, 83:835-844.
5. Erkkila A.T., Booth S.L., Hu F.B., Jacques P.F., Manson J.E., Rexrode K.M., et al. Phylloquinone intake as a marker for coronary heart disease risk but not stroke in women. Eur J Clin Nutr 2005, 59:196-204.
6. Erkkila A.T., Booth S.L., Hu F.B., Jacques P.F., Lichtenstein A.H. Phylloquinone intake and risk of cardiovascular diseases in men. Nutr Metab Cardiovasc Dis 2007, 17:58-62.
7. Geleijnse J.M., Vermeer C., Grobbee D.E., Schurgers L.J., Knapen M.H., van der Meer I.M., et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. JNutr 2004, 134:3100-3105.
8. Gast G.C., de Roos N.M., Sluijs I., Bots M.L., Beulens J.W., Geleijnse J.M., et al. Ahigh menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis 2009, 19:504-510.
9. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS) National health and nutrition examination survey data 1996, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, MD, [1988-1994].
10. Levey A.S., de Jong P.E., Coresh J., El Nahas M., Astor B.C., Matsushita K., et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 2011, 80:17-28.
11. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. Anew equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
12. Sato Y., Honda Y., Kuno H., Oizumi K. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. Bone 1998, 23:291-296.
13. Kamao M., Suhara Y., Tsugawa N., Uwano M., Yamaguchi N., Uenishi K., et al. Vitamin K content of foods and dietary vitamin K intake in Japanese young women. JNutr Sci Vitaminol (Tokyo) 2007, 53:464-470.
14. NHANES III dietary interviewers manual 1992, Centers for Disease Control and Prevention.
15. National vital statistics system homepage 2012, Centers for Disease Control and Prevention.
16. Nimptsch K., Rohrmann S., Kaaks R., Linseisen J. Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am J Clin Nutr 2010, 91:1348-1358.
17. Hayes J., Kalantar-Zadeh K., Lu J.L., Turban S., Anderson J.E., Kovesdy C.P. Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race. Nephron Clin Pract 2012, 120:c8-16.
18. Deubner N., Berliner D., Frey A., Guder G., Brenner S., Fenske W., et al. Dysnatraemia in heart failure. Eur J Heart Fail 2012, 14:1147-1154.
19. Cheung C.L., Tan K.C., Lam K.S., Cheung B.M. The relationship between glucose metabolism, metabolic syndrome, and bone-specific alkaline phosphatase: a structural equation modeling approach. JClin Endocrinol Metab 2013, 98:3856-3863.
20. Breslow R.A., Smothers B.A. Drinking patterns and body mass index in never smokers: National Health Interview Survey, 1997-2001. Am J Epidemiol 2005, 161:368-376.
21. Looker A.C., Dawson-Hughes B., Calvo M.S., Gunter E.W., Sahyoun N.R. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002, 30:771-777.
22. Booth S.L., Broe K.E., Gagnon D.R., Tucker K.L., Hannan M.T., McLean R.R., et al. Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr 2003, 77:512-516.
23. Park Y., Subar A.F., Hollenbeck A., Schatzkin A. Dietary fiber intake and mortality in the NIH-AARP diet and health study. Arch Intern Med 2011, 171:1061-1068.
24. Cheung C.L., Lam K.S., Cheung B.M. Serum beta-2 microglobulin concentration predicts cardiovascular and all-cause mortality. Int J Cardiol 2013, 168:4811-4813.
25. Cheung C.L., Lam K.S., Cheung B.M. Serum beta-2 microglobulin predicts mortality in people with diabetes. Eur J Endocrinol 2013, 169:1-7.
26. Holden R.M., Sanfilippo A.S., Hopman W.M., Zimmerman D., Garland J.S., Morton A.R. Warfarin and aortic valve calcification in hemodialysis patients. JNephrol 2007, 20:417-422.
27. Shea M.K., Dallal G.E., Dawson-Hughes B., Ordovas J.M., O'Donnell C.J., Gundberg C.M., et al. Vitamin K, circulating cytokines, and bone mineral density in older men and women. Am J Clin Nutr 2008, 88:356-363.
28. Beulens J.W., van der A.D., Grobbee D.E., Sluijs I., Spijkerman A.M., van der Schouw Y.T. Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes. Diabetes Care 2010, 33:1699-1705.
29. Apalset E.M., Gjesdal C.G., Eide G.E., Tell G.S. Intake of vitamin K1 and K2 and risk of hip fractures: the Hordaland Health Study. Bone 2011, 49:990-995.
30. Greenwood D.C., Gilthorpe M.S., Golding C., Cade J.E. Stability over time of dietary patterns in the UK Women's Cohort Study. Proc Nutr Soc 2003, 62:89A.